Loading provider…
Loading provider…
Medical Oncology Physician in Ann Arbor, MI
NPI: 1356427314Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH SYSTEM
1540 E Hospital Dr, Ann Arbor, MI
Primary Employer
Regents of the University of Michigan
michiganmedicine.org
HQ Phone
Get MD Rashmi's Phone Numberphone_androidMobile
Get MD Rashmi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 56 | 100 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 75 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 31 | 35 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 28 | 28 |
Next generation sequencing of extraskeletal myxoid chondrosarcoma.
Authors: Scott Schuetze, Laurence Baker
Journal: Oncotarget
Authors: Brigitte Widemann, Sant Chawla, Scott Okuno, Alice Chen, John Perentesis
Journal: Sarcoma
Publication Date: 2020-01-30
Authors: Herbert Hurwitz, John Strickler
Journal: Cancer Chemother Pharmacol
Publication Date: 2015-02-27
Lead Sponsor: Sarcoma Alliance for Research through Collaboration
Collaborators: Janssen Scientific Affairs, LLC, National Institutes of Health (NIH), National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Irinotecan, DRUG: Trabectedin 1 MG [Yondelis], DIAGNOSTIC_TEST: tumor biopsy, OTHER: 3'-Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging
Lead Sponsor: Taiho Oncology, Inc.
Intervention / Treatment: DRUG: ASTX295
Lead Sponsor: Gulam Manji
Collaborators: Daiichi Sankyo
Intervention / Treatment: DRUG: sirolimus, DRUG: PLX3397